Resultados de procura - Robert C. Doebele

Limitar resultados
  1. 1
    Targeted Therapies in Non-Small Cell Lung Cancer: Emerging Oncogene Targets Following the Success of Epidermal Growth Factor Receptor

    Targeted Therapies in Non-Small Cell Lung Cancer: Emerging Oncogene Targets Following the Success of Epidermal Growth Factor Receptor por Eamon M. Berge, Robert C. Doebele

    Publicado 2013
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Treating ALK-positive lung cancer—early successes and future challenges

    Treating ALK-positive lung cancer—early successes and future challenges por D. Ross Camidge, Robert C. Doebele

    Publicado 2012
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Molecular Pathways: ROS1 Fusion Proteins in Cancer

    Molecular Pathways: ROS1 Fusion Proteins in Cancer por Kurtis D. Davies, Robert C. Doebele

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    A framework for understanding and targeting residual disease in oncogene-driven solid cancers

    A framework for understanding and targeting residual disease in oncogene-driven solid cancers por Trever G. Bivona, Robert C. Doebele

    Publicado 2016
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    TRKing Down an Old Oncogene in a New Era of Targeted Therapy

    TRKing Down an Old Oncogene in a New Era of Targeted Therapy por Aria Vaishnavi, Anh‐Tuan Le, Robert C. Doebele

    Publicado 2014
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  6. 6
    PrlA and PrlG suppressors reduce the requirement for signal sequence recognition

    PrlA and PrlG suppressors reduce the requirement for signal sequence recognition por Ann M. Flower, Robert C. Doebele, Thomas J. Silhavy

    Publicado 1994
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Determination of the HLA-DM Interaction Site on HLA-DR Molecules

    Determination of the HLA-DM Interaction Site on HLA-DR Molecules por Robert C. Doebele, Robert Busch, Hyman M. Scott, Achal Pashine, Elizabeth Mellins

    Publicado 2000
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Adding to the Mix: Fibroblast Growth Factor and Platelet-Derived Growth Factor Receptor Pathways as Targets in Non – small Cell Lung Cancer

    Adding to the Mix: Fibroblast Growth Factor and Platelet-Derived Growth Factor Receptor Pathways as Targets in Non – small Cell Lung Cancer por Scott A. Kono, Lynn E. Heasley, Robert C. Doebele, D. Ross Camidge

    Publicado 2012
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  9. 9
    A Changing of the Guard: Immune Checkpoint Inhibitors With and Without Chemotherapy as First Line Treatment for Metastatic Non-small Cell Lung Cancer

    A Changing of the Guard: Immune Checkpoint Inhibitors With and Without Chemotherapy as First Line Treatment for Metastatic Non-small Cell Lung Cancer por Jose M. Pacheco, D. Ross Camidge, Robert C. Doebele, Erin L. Schenk

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  10. 10
    Diagnostic assays for identification of anaplastic lymphoma kinase‐positive non–small cell lung cancer

    Diagnostic assays for identification of anaplastic lymphoma kinase‐positive non–small cell lung cancer por Andrew Weickhardt, Dara L. Aisner, Wilbur A. Franklin, Marileila Varella‐Garcia, Robert C. Doebele, D. Ross Camidge

    Publicado 2012
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  11. 11
    Anthrax Edema Toxin Inhibits Endothelial Cell Chemotaxis via Epac and Rap1

    Anthrax Edema Toxin Inhibits Endothelial Cell Chemotaxis via Epac and Rap1 por Jia Hong, Robert C. Doebele, Mark W. Lingen, Lawrence A. Quilliam, Wei‐Jen Tang, Marsha Rich Rosner

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Stereotactic Radiation Therapy can Safely and Durably Control Sites of Extra-Central Nervous System Oligoprogressive Disease in Anaplastic Lymphoma Kinase-Positive Lung Cancer Patients Receiving Crizotinib

    Stereotactic Radiation Therapy can Safely and Durably Control Sites of Extra-Central Nervous System Oligoprogressive Disease in Anaplastic Lymphoma Kinase-Positive Lung Cancer Pati... por Gregory N. Gan, Andrew Weickhardt, Benjamin Scheier, Robert C. Doebele, Laurie E. Gaspar, Brian D. Kavanagh, D. Ross Camidge

    Publicado 2014
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Interaction of HLA-DR with an Acidic Face of HLA-DM Disrupts Sequence-Dependent Interactions with Peptides

    Interaction of HLA-DR with an Acidic Face of HLA-DM Disrupts Sequence-Dependent Interactions with Peptides por Achal Pashine, Robert Busch, Michael P. Belmares, Jason N. Munning, Robert C. Doebele, Megan Buckingham, Garry P. Nolan, Elizabeth Mellins

    Publicado 2003
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer

    An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer por Rafał Dziadziuszko, Anh T. Le, Anna Wrona, Jacek Jassem, D. Ross Camidge, Marileila Varella‐Garcia, Dara L. Aisner, Robert C. Doebele

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Rapid‐onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer

    Rapid‐onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer por Andrew Weickhardt, Micol S. Rothman, Smita Salian‐Mehta, Katja Kiseljak‐Vassiliades, Ana B. Oton, Robert C. Doebele, Margaret E. Wierman, D. Ross Camidge

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer

    A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced... por Robert C. Doebele, Paul Conkling, Anne M. Traynor, Gregory A. Otterson, Yanyan Zhao, Sven Wind, Peter Stopfer, R. Kaiser, D. Ross Camidge

    Publicado 2012
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Dramatic Response to Crizotinib in a Patient With Lung Cancer Positive for an <i>HLA-DRB1-MET</i> Gene Fusion

    Dramatic Response to Crizotinib in a Patient With Lung Cancer Positive for an <i>HLA-DRB1-MET</i> Gene Fusion por Kurtis D. Davies, Terry L. Ng, Adriana Estrada‐Bernal, Anh T. Le, Peter R. Ennever, D. Ross Camidge, Robert C. Doebele, Dara L. Aisner

    Publicado 2017
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Optimizing the Detection of Lung Cancer Patients Harboring Anaplastic Lymphoma Kinase (<i>ALK</i>) Gene Rearrangements Potentially Suitable for ALK Inhibitor Treatment

    Optimizing the Detection of Lung Cancer Patients Harboring Anaplastic Lymphoma Kinase (<i>ALK</i>) Gene Rearrangements Potentially Suitable for ALK Inhibitor Treatment por D. Ross Camidge, Scott A. Kono, Antonella Flacco, Aik Choon Tan, Robert C. Doebele, Qing Zhou, Lucio Crinò, Wilbur A. Franklin, Marileila Varella‐Garcia

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapy

    Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapy por Caroline E. McCoach, Gideon M. Blumenthal, L. Zhang, Adrian Myers, Shenghui Tang, R. Sridhara, Patricia Keegan, Richard Pazdur, Robert C. Doebele, Dickran Kazandjian

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples

    Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples por Kurtis D. Davies, Anh‐Tuan Le, Jamie Sheren, Hala Nijmeh, Katherine Gowan, Kenneth L. Jones, Marileila Varella‐Garcia, Dara L. Aisner, Robert C. Doebele

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: